咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Mi R-122 in hepatitis B virus ... 收藏

Mi R-122 in hepatitis B virus and hepatitis C virus dual infection

Mi R-122 in hepatitis B virus and hepatitis C virus dual infection

作     者:Kyoungsub Song Chang Han Srikanta Dash Luis A Balart Tong Wu 

作者机构:Department of Pathology and Laboratory Medicine Tulane University School of Medicine Department of Medicine Tulane University School of Medicine 

出 版 物:《World Journal of Hepatology》 (世界肝病学杂志(英文版)(电子版))

年 卷 期:2015年第7卷第3期

页      面:498-506页

学科分类:1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基  金:Supported by Grants from NIDDK and NCI 

主  题:MiR-122 Hepatitis B virus Hepatitis C virus Hepatitis B virus/hepatitis C virus dual infection 

摘      要:Hepatitis B virus(HBV) and hepatitis C virus(HCV) infections are the most common causes of chronic liver diseases and hepatocelluar carcinomas. Over the past few years, the liver-enriched micro RNA-122(mi R-122) has been shown to differentially regulate viral replication of HBV and HCV. It is notable that thelevel of mi R-122 is positively and negatively regulated by HCV and HBV, respectively. Consistent with the welldocumented phenomenon that mi R-122 promotes HCV accumulation, inhibition of mi R-122 has been shown as an effective therapy for the treatment of HCV infection in both chimpanzees and humans. On the other hand, mi R-122 is also known to block HBV replication, and HBV has recently been shown to inhibit mi R-122 expression; such a reciprocal inhibition between mi R-122 and HBV suggests an intriguing possibility that mi R-122 replacement may represent a potential therapy for treatment of HBV infection. As HBV and HCV have shared transmission routes, dual infection is not an uncommon scenario, which is associated with more advanced liver disease than either HBV or HCV mono-infection. Thus, there is a clear need to further understand the interaction between HBV and HCV and to delineate the role of mi R-122 in HBV/HCV dual infection in order to devise effective therapy. This review summarizes the current understanding of HBV/HCV dual infection, focusing on the pathobiological role and therapeutic potential of mi R-122.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分